Investing in the AI infrastructure for home health
Every day, more than 10,000 Americans turn 65. By 2030, the U.S. will be home to 73 million seniors, with 7 out of 10 needing long-term care. The vast majority would rather receive that care at home than in a facility.
That preference is driving one of the most consequential shifts in American healthcare, and it's running headfirst into a system that isn't ready for it.
Home health agencies are caught in a vise. On one side, demand is surging. On the other hand, Medicare reimbursement cuts, tightening regulations, and a brutal labor shortage are squeezing margins to the breaking point.
Clinician turnover in home health hovers near 80% within the first 100 days, because so much of nurses’ time is consumed by documentation, coding, compliance, and administrative overhead rather than patient care.*
Due to the massive volume of administrative work, 60% of in-home health referrals are denied simply because agencies lack the capacity to take them on.**
This is a massive structural problem, and it's the one Enzo Health is solving. Which is why we’re excited to share that N47 is leading Enzo Health’s Series A, bringing total funding to $26M!
Enter: Enzo
Enzo Health is an AI-native platform purpose-built for home health and post-acute care. Enzo connects the entire workflow (from referral intake to clinical documentation to quality assurance to reimbursement) in a single system.
Three modules form the core today:
- Enzo Intake converts the flood of faxes, emails, and PDFs that agencies receive into structured, actionable data. It verifies insurance, validates diagnoses, and checks eligibility in seconds.
- Enzo Scribe automates OASIS documentation and clinical charting in real time during patient visits, so nurses finish their paperwork before they leave the home.
- Enzo QA continuously reviews charts for clinical and regulatory accuracy, catching issues before they affect reimbursement or trigger compliance problems.
The results are striking. One customer cut intake processing time by 90%. Documentation time per visit dropped from nearly an hour to 20 minutes. QA backlogs that used to stretch days were resolved within 24 hours. One agency cut its administrative staff by 50% while growing its patient base by over 40% with the same number of clinicians. Across the board, customers report dramatically improved nurse satisfaction and retention.
Why now?
Home health has historically been resistant to automation, and for good reason. Clinical documentation in this space is extraordinarily nuanced.
What's changed is the maturity of large language models and voice AI.
For the first time, it's possible to build systems that genuinely understand clinical language, reason about complex medical documentation, and produce structured output that meets regulatory standards. Enzo has seized this moment.
As Enzo embeds deeper into daily clinical workflows, it captures a growing corpus of expert-labeled medical documentation that no competitor has access to.
Enzo has architected a system of multiple coordinated AI agents for tasks such as intake, scribe, QA, and coding that share context and learn from one another. This is what allows them to automate entire workflows end-to-end rather than optimizing isolated tasks. It's the difference between giving an agency a better tool and fundamentally changing how the agency operates.
Why Enzo stands out
The team ships fast and has deep domain credibility
CEO Zach Newman was the former Head of Sales at Athelas (acquired by Commure for $6B). Co-founder Dan Conger and CTO Travis Elnicky were among the first ten employees at Podium, with Travis as its chief architect. They've attracted exceptional technical talent, and their product velocity is legitimately best-in-class for a company at this stage.
In just over a year of monetization, they've shipped intake automation, an AI scribe, QA, and coding automation.
Customers love the product, and they keep buying more
Enzo has achieved best-in-class customer retention and net dollar retention.
These are some of the best customer reference calls I’ve had in my venture career, with customers sharing that Enzo far outperforms existing software.
A publicly traded national provider described Enzo as a strategic partner and is budgeting a 7-figure range for Enzo services next year. Multiple customers gave NPS scores of 9 or higher. In an industry where the incumbent software vendors are broadly disliked, that kind of customer love is rare and meaningful.
The wedge-to-platform strategy is working
Enzo starts by solving an acute pain point, usually intake or QA, and then expands across the workflow. Most customers begin with one module and add more over time.
The long-term vision is to be the AI-native system of record for post-acute care, replacing the legacy incumbents that agencies are desperate to move away from.
The market is massive and underserved
Home health alone represents an $825M software TAM, and the broader post-acute market (inclusive of skilled nursing, hospice, and other settings) is multiples larger. The existing vendors in this space are stagnating, and customers are actively looking for something better.
Enzo has the potential to become the defining platform in this category.
Conclusion
With this round, Enzo is expanding into skilled nursing and hospice and extending its platform to address the distinct clinical and regulatory workflows of each setting.
We're thrilled to lead Enzo Health's Series A, with participation from Gradient Ventures, Tandem Ventures, and Rigby Watts.
Home health is foundational to how America will care for its aging population, and the agencies delivering that care deserve technology that actually works for them. Zach, Dan, Travis, and the entire Enzo team are building exactly that, and we're excited to be their partners in scaling it.
*Source: 2024 Activated Insights Benchmarking Report
**Source: Home Health Care News
